Background Liothyronine (LT3) has been increasingly used in combination with levothyroxine (LT4) in the treatment of hypothyroidism. A metal coordinated form of LT3, known as poly-zinc-liothyronine (PZL), avoided in rats the typical T3 peak seen after oral administration of LT3.

中文翻译：

---

人体内从聚锌碘酒 (PZL) 中延长碘酒的吸收

背景碘甲状腺氨酸 (LT3) 越来越多地与左甲状腺素 (LT4) 联合用于治疗甲状腺功能减退症。LT3 的金属配位形式，称为聚锌碘塞罗宁 (PZL)，避免了大鼠口服 LT3 后出现的典型 T3 峰。